Vivan Therapeutics

26/08/2026

Every tumor carries its own story, written in its own genes — and that story matters when it comes to treatment. TuMatch™ looks at your tumor’s own genetic signature to recommend what’s most likely to help, instead of a one-size-fits-all approach.

Currently available for Gastrointestinal cancers, with more on the way.

Contact us to learn more: [email protected]

26/08/2026

Every tumor carries its own story, written in its own genes — and that story matters when it comes to treatment. TuMatch™ looks at your tumor’s own genetic signature to recommend what’s most likely to help, instead of a one-size-fits-all approach.

Currently available for GI cancers, with more on the way.

Contact us to learn more: [email protected]

25/08/2026

One of our published case studies: a real patient’s tumor, before and after. 🧬

Up to 45% shrinkage in a colorectal cancer that had stopped responding to chemo. Found through PDP (Personal Discovery Process): our process of screening thousands of drug combinations against a patient’s own unique tumor profile.

It’s one of our published, peer-reviewed studies of the technology behind TuMatch™ — our AI software now matching GI cancer patients to treatment recommendations, with more cancer types on the way.

If we do not instantly identify a TuMatch™ for you, PDP steps in — essentially a personalized clinical trial built entirely around your tumor.

Know someone facing a hard-to-treat cancer? Save this post, send us a DM or email us at [email protected]

(Both studies linked in our bio.)

22/08/2026

If you or someone you love is living with cancer, you could already have a personalized treatment option waiting for you. 🧬

TuMatch™ securely checks your existing genomic profiling report against data gathered from thousands of tumor profiles — Vivan’s own proprietary drug-screening dataset, combined with publicly available clinical data. Often within minutes, it identifies novel combinations of targeted agents and non-cancer drugs for your unique tumor, making treatment less toxic and more effective, even for cancers that have been difficult to treat. Every recommendation, with dosing information, comes together in one clear report you can share with your oncologist.

Many choose to do this alongside their current treatment simply for peace of mind: having options already explored, should you ever need to consider next steps; a clearer sense of how your current treatment is likely to work; and insight into clinical trials that may be relevant to you.

Already have a genomic profiling report? Upload it securely to find out: link in bio.

Don’t have one yet? Send us a message, or email us at [email protected] — we’ll guide you through it.

21/08/2026

20/08/2026

Meet the fruit flies fighting cancer. 🪰🧬

In this clip from her conversation on Amplified by Hub71, our Founder & CEO Laura Towartexplains the foundational science behind Vivan Therapeutics: building genetically matched fruit fly “avatars” of a patient’s tumour — the technology that underpins our AI-powered software tool, TuMatch™.

At Vivan, we’re a precision oncology biotech company on a mission to make every cancer treatment decision truly personal. Rather than the trial-and-error approach still used across much of cancer care, we test how a patient’s own tumour responds across thousands of drug combinations using real biological models. TuMatch™ then builds on this, using AI to identify the most effective treatment combinations for an individual’s unique tumour biology — rapidly, and with an initial focus on gastrointestinal cancer.

This clip is just one part of a longer conversation on Amplified by Hub71, where Laura also talks candidly about what it takes to build a science-driven start-up, and why Abu Dhabi is emerging as a serious hub for the next generation of health tech. Full episode linked in our bio.

Interested in partnering or collaborating with Vivan? Reach out — we’re always open to new conversations.

If you or someone you love is navigating a cancer diagnosis and want to understand whether our approach could be relevant, send us a message.

[email protected]

16/08/2026

Thank you to Entrepreneur Middle East for inviting our CEO Laura Towart to share our experience launching in the UAE. We are now scaling operations to transform cancer management through treatment personalization coloncancer

14/08/2026

We’re delighted to have been featured in the 15 August issue of Entrepreneur Middle East, exploring Abu Dhabi’s emergence as a deep-tech healthcare destination.

We personalise cancer treatment by matching patients with drug combinations tailored to their tumour genetics. We are seeking growth funding to establish an advanced R&D centre in Masdar City and expand our vision across the GCC.

Our plans include integrating TuMatch™️, our clinical decision-support software; establishing a world-first hub for treating cancer patients with diabetes; and developing a robotics-driven disease-modelling and high-throughput drug-screening facility.

The centre would generate unique datasets across cancer, genetic diseases and longevity, helping to power next-generation AI foundation models while positioning Abu Dhabi at the forefront of personalised medicine.

It is especially meaningful to feature in an issue celebrating Emirati Women’s Day and the region’s commitment to supporting women founders.

Entrepreneur ME Hub71 Burjeel Medical City Burjeel Medical City Cleveland Clinic Abu Dhabi

30/07/2026

We’re thrilled to announce that Vivan Therapeutics has been shortlisted for STEM³ Business of the Year at the Hammersmith & Fulham Business Awards 2026! 🎉

This category celebrates local organisations driving genuine innovation, strong commercial growth and measurable impact — and we’re honoured to be shortlisted alongside such a strong field of finalists.

The recognition reflects the work of our team and our mission to advance precision oncology through TuMatch, our AI-powered platform delivering rapid, personalised cancer treatment recommendations.

Thank you to the Hammersmith & Fulham Business Awards team — we’re looking forward to celebrating with the other finalists at the ceremony!

Hammersmith & Fulham Council

13/07/2026

A more precise cancer treatment is calling. Will you answer?

Every cancer is unique. Every patient deserves treatment recommendations tailored precisely to the biology of their disease.

At Vivan Therapeutics, we’re advancing precision oncology by combining comprehensive genomic analysis with innovative disease modeling to identify and rank personalized treatment options for patients facing hard-to-treat cancers.

The result? Personalized treatment reports designed to help oncologists make more informed decisions—delivered in days.

Because the future of cancer care isn’t one-size-fits-all. It’s personal.

Learn more at www.vivantx.com or reach out to us at [email protected]